cjc - 1295 / ipamorelin 12mg & No DAC 6mg CJC-1295 No DAC & Ipamorelin

Consult a healthcare provider if you experience any adverse effects, have questions about the dosage, or need guidance on the proper use and handling of Semaglutide

Niu et al

***Expiry date is MAY 2026 but the print has been partially erased

MOTS-c vs NAD+: How Two Mitochondrial Compounds Compare and When a Clinic Uses Both MOTS-c and NAD+ both target mitochondrial function, but through different pathways

Retatrutide: Complication Focus TRIUMPH-4: Obesity + knee osteoarthritis (445 participants) TRIUMPH-2: Obesity + type 2 diabetes TRIUMPH-6: Weight maintenance trial Advantage: Multiple complication-specific trials could lead to broader label (obesity + OA + OSA indications)

American Journal of Cardiovascular Disease